Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve the audited results for the quarter and financial year ended on 31st March, 2026 and to consider recommendation of dividend, if any.